JnA_Sole_Source_Redacted.pdf

PDF 290 KB Posted

Attached to
Opera Phenix Maintenance Agreement for Multiple Units Federal contract opportunity
Solicitation number
75N95022P00132
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

About this file

This document is a justification and approval for a sole source contract award. The National Institutes of Health National Institute on Drug Abuse requires maintenance services for several Opera Phenix and Operetta CLS imaging systems from PerkinElmer Health Sciences, Inc. The sole source award of contract number 75N95022P00132 was made on February 15, 2022 for an unknown amount to support the systems from February 22, 2022 through February 21, 2023. PerkinElmer is the original manufacturer of the equipment and sole provider of factory-trained service engineers and genuine spare parts required to maintain the sensitive research equipment. Market research found no other capable sources.

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Justification and Approval for Sole Source

Source Selection Information – see FAR 2.101 and 3.104

1. Identification of the agency and contracting activity.

a. Federal agency and contracting activity.

Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA)

b. Sponsoring organization.

National Center for Advancing Translational Sciences (NCATS) Division of Preclinical Innovation (DPI)

c. Project Officer information.

9800 Medical Center Drive, 1018B Rockville, MD 20850

2. Nature and/or description of the action being approved.

a. Acquisition purpose and objectives.

NCATS requires a maintenance agreement for Operetta CLS Serial Numbers 1600L16048 and 1600L16049 and Opera Phenix Serial Numbers 1400L14042, 1400L18179 and 1400L18183, PHF-030 and 2400L20045.

b. Project background.

NCATS is tasked with identifying and developing novel small molecule leads against a wide spectrum of human and infectious disease targets, which it accomplishes by screening thousands of small molecules in collaboration with both intra- and extramural researchers. To this end, NCATS has existing high throughput screening (HTS) microplate-based automated imaging systems to monitor and record cellular-level biological activities or changes in intact, living cells. These instruments are used to measure and analyze stem cell growth and differentiation as well as phenotypic screening.

The purpose of this acquisition is to obtain a maintenance agreement to support these HTS imaging systems.

3. Description of the supplies or services required to meet the agency’s needs (including the estimated value).

a. Project title: Opera Phenix Maintenance Agreement for Multiple Units

b. Project description.

Requirement type. Check the appropriate box:

Research & development (R&D) R & D support services Support services (non-R&D) Supplies/equipment Information technology (IT) Construction Architect-engineer (A & E) services Design-build Other (specify): ____________________

Type of action. Check the appropriate box:

New requirement Follow-on Other (specify): Previous contracts awarded for similar services include Purchase Order Numbers 75N95021P00100 and 75N95019P00565.

Proposed contract/order type. Check all that apply:

Firm-fixed-price Other fixed-price (specify, e.g., fixed-price award-fee, fixed-price incentive-fee): __________

Cost-plus-fixed-fee Other cost reimbursement (specify, e.g., cost-plus-award-fee, cost-plus-incentive-fee): ___________

Time and materials Indefinite delivery (specify whether indefinite quantity, definite quantity, or requirements): ___________ Other (specify): ___________ Completion Form Term form

Acquisition identification number.

Solicitation ID 75N95022Q00101 Requisition # 6240567 / POTS ID 22-001918

c. Total estimated dollar value and performance/delivery period.

with a period of performance of 02/22/2022 through 02/21/2023.

4. Identification of the statutory authority permitting other than full and open competition.

This acquisition is conducted under the authority of FAR subpart 13.5 in accordance with 41 U.S.C. 1901. Simplified Acquisition Procedures.

This acquisition is conducted under the authority of FAR subpart 13.5 in accordance with 41 U.S.C. 1903. Special emergency procurement authority.

5. Demonstration that the proposed contractor(s) unique qualifications or the nature of the acquisition requires use of the authority cited.

a. Name and address of the proposed contractor(s).

PerkinElmer Health Sciences, Inc.

710 Bridgeport Avenue Shelton, CT 06484-4794

(800) 762-4000

b. Nature of the acquisition and proposed unique qualifications of the contractor(s).

PerkinElmer Health Sciences, Inc. is the manufacturer of this equipment, and they are the only source and provider for factory trained and certified service engineers and factory-new or re-manufactured repair parts for this equipment. PerkinElmer does not authorize or certify third parties to provide these services.

These are very sensitive pieces of equipment, and as such require a technician who has experience with this exact make & model. Knowledge of other brands in general will not suffice as it may result in improper repairs. Genuine Perkin Elmer trained technicians are needed to supply genuine parts and repairs and have been successfully completing repairs as well as preventative maintenance since these units were acquired starting in 2014.

6. Description of the efforts made to ensure that offers are solicited from as many potential sources as practicable. Indicate whether a notice was or will be publicized on the governmentwide point of entry as required by FAR Subpart 5.2 and, if not, which exception under FAR 5.202 applies.

This acquisition will be synopsized on the governmentwide point of entry. Any interested party may submit a capability statement, proposal, or quotation, which shall be considered by the agency.

7. Determination by the Contracting Officer that the anticipated cost/price to the Government will be fair and reasonable.

The prices for comparable items sold in the commercial marketplace will be used to confirm that the price for these items is fair and reasonable. A determination that the final quotation price is fair and reasonable will be made and documented in accordance with FAR 13.106-3(a) and (b).

8. Description of the market research conducted (see FAR Part 10) and the results, or a statement of the reasons market research was not conducted.

Research conducted by the Contracting Officer on the UNICOR, AbilityOne, and GSA Advantage websites produced no results. PerkinElmer is the sole source to provide these services. Market research is documented in the acquisition file.

9. Any other facts supporting the use of other than full and open competition.

PerkinElmer Health Sciences, Inc. is the manufacturer of this equipment, and they are the sole provider of repair and preventative maintenance services for them. PerkinElmer is the only source for the factory trained and certified service engineers and the factory-new or re-manufactured repair parts needed to perform these services on this equipment. PerkinElmer does not authorize or certify third parties to provide these services.

10. Listing of sources, if any, that expressed, in writing, an interest in the acquisition.

N/A.

11. Statement of the actions, if any, the agency may take to remove or overcome any barriers to competition before any subsequent acquisition for the required supplies or services.

Before any subsequent acquisition of the same required services, the Government will synopsize the requirement on the governmentwide point of entry so any interested party may submit a capability statement, proposal, or quotation, which shall be considered by the agency in determining the appropriate competitive strategy for the requirement.

File details come from the government source that posted it. Updated .